What is it about?
An updated approach in differential diagnosis of LAM and other diffuse cystic lung diseases, and the current development in management.
Featured Image
Why is it important?
LAM, or lymphangioleiomyomatosis, is a typical example of diffuse cystic lung diseases. This review summarized the differential diagnosis of diffuse cystic lung diseases. Also, we introduced our experience in clinical application of sirolimus.
Perspectives
Precision and individulized diagnosis and treatment of diffuse cystic lung diseases, including LAM, is the next step.
Professor Kai-Feng Xu
Peking Union Medical College
Read the Original
This page is a summary of: Lymphangioleiomyomatosis: differential diagnosis and optimal management, Therapeutics and Clinical Risk Management, August 2014, Taylor & Francis,
DOI: 10.2147/tcrm.s50784.
You can read the full text:
Contributors
The following have contributed to this page
